At the request of the authors, the Lancet has retracted a controversial study
on the use of malaria drugs chloroquine and hydroxychloroquine to treat
COVID-19 patients. The data, published on May 22, suggested that their
use was associated with higher mortality risk and increased frequency of
ventricular arrhythmias.
The authors, who were not directly involved with
data collection, felt that they could no longer vouch for the veracity
of the primary data sources.
A study
published this week in the New England Journal of Medicine showed that
hydroxychloroquine failed to demonstrate a treatment benefit in
preventing COVID-19 in at-risk people above and beyond placebo.
https://seekingalpha.com/news/3580569-lancet-retracts-paper-raised-concerns-safety-of-malaria-drugs
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.